SLC5A2 and kidney failure: Population-wide screening for albuminuria followed by treatment with conventional CKD therapy and SGLT2 inhibitors reduced the burden of kidney failure requiring KRT across all age groups compared with status quo case finding with conventional CKD therapy alone (Figure 1).